Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Luspatercept in Chinese Adults With Transfusion Dependent β-thalassemia
NCT05462548Phase 4Unknown
- Sponsor
- Sun Yat-sen University
- Start
- Jul 2022
- Primary completion
- Feb 2023
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 4 trial of luspatercept in beta thalassemia, sponsored by Sun Yat-sen University. Status: unknown.
02
Drugs
luspatercept
03
Conditions
beta thalassemia
Beyond the preview
Go deeper on NCT05462548.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05462548.